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Abstract: Ubiquitin-fold modifier 1 (UFM1) is a reversible
post-translational modifier that is covalently attached to target
proteins through an enzymatic cascade and removed by
designated proteases. Abnormalities in this process, referred
to as Ufmylation, have been associated with a variety of human
diseases. Given this, the UFM1-specific enzymes represent
potential therapeutic targets; however, understanding of their
biological function has been hampered by the lack of chemical
tools for activity profiling. To address this unmet need,
a diversifiable platform for UFM1 activity-based probes
(ABPs) utilizing a native chemical ligation (NCL) strategy
was developed, enabling the generation of a variety of tools to
profile both UFM1 conjugating and deconjugating enzymes.
The use of the probes is demonstrated in vitro and in vivo for
monitoring UFM1 enzyme reactivity, opening new research
avenues.
Post-translational modification (PTM) of proteins by chem-
ical groups, peptides, complex molecules, or even small
proteins facilitates dynamic protein diversification to modu-
late cellular responses. Ubiquitination is one of the most
common PTMs and a number of Ub-like proteins (Ubls) have
been subsequently identified. Ubiquitin-fold modifier
1 (UFM1) is one of the recently identified Ubls and displays
a similar tertiary structure, yet it has little sequence identity to
Ubiquitin (Ub).[1] Analogous to ubiquitin, it is covalently
attached to the lysine residues of its substrates by the
sequential action of three dedicated enzymes-E1 (UBA5),
E2 (Ufc1), and E3 (Ufl1) and is cleaved by UFM1-specific
proteases (Ufsps).[2] This process, referred to as Ufmylation, is
initiated by the adenylation of the exposed C-terminal glycine
of mature UFM1 and subsequent nucleophilic reaction with
the active-site cysteine of UBA5. The resulting high-energy
thioester bond allows the transfer onto the catalytic site
cysteine of the E2 enzyme Ufc1, in a trans-thioesterification
reaction. Lastly, the E3-like enzyme Ufl1 mediates the
transfer of activated UFM1 onto the lysine residues of the
protein substrates resulting in the formation of an isopeptide
linkage. In addition to releasing UFM1 from its substrates, the
UFM1 specific proteases-Ufsp1 and Ufsp2-mediate the
maturation of pro-UFM1.[3] Although Ufmylation has been
connected to biological processes including ER homeosta-
sis,[4–6] vesicle trafficking,[5] blood progenitor development
and differentiation,[7, 8] G-coupled protein receptor (GPCR)
maturation,[9] transcriptional control,[10] mitosis,[11] and
autophagy,[7, 12] the underlying mechanisms remain to be
studied. Furthermore, abnormalities in the UFM1 cascade
are reported to be associated with a number of human
diseases, including cancer,[13] diabetes,[14] schizophrenia,[15]
and ischemic heart disease[6] and to play a pivotal role in
embryonic development and hematopoiesis.[8, 16] Notwith-
standing the biochemical and structural studies of UFM1-
conjugating and deconjugating enzymes that have been
undertaken,[17–21] their biological function remains enigmatic
primarily owing to the lack of activity-based reagents. By
contrast, diverse reagents and ABPs have been developed for
both Ub-conjugating and deconjugating enzymes[22–27] and
have been expanded to Ubls such as SUMO[28–30] and
Nedd8.[24, 26] This advancement of assay and activity-based
reagents has greatly propelled discoveries in the ubiquitin
field, yet such a diversifiable synthetic platform for UFM1
needs to be developed.[31] While UFM1 has been prepared
using multiple segment ligations based on KAHA chemistry,
this is a time-consuming process requiring the incorporation
of a (S)-5-oxaproline building block at multiple sites.[32] We
first attempted to generate UFM1 using linear solid-phase
peptide synthesis (SPPS) by incorporating aggregation break-
ers such as pseudoproline[33] at permissible sites (Supporting
Information, Figure S1). Although this linear synthesis
approach yields full-length UFM1, which has been utilized
in a recent study,[34] the synthesis wasnQt efficient, presumably
owing to inefficient coupling of amino acid 36 onwards (see
Figure S2). To circumvent this issue, we present herein a more
practical two-segment native chemical ligation (NCL)
approach[35,36] towards full-length UFM1 and UFM1 activ-
ity-based reagents (Figure 1). Given the increasing knowl-
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edge on the importance of UFM1, our synthetic strategy gives
access to valuable tools that allow the in vitro and in vivo
characterization of enzymatic activity, thereby enabling
insights into the dynamics of Ufmylation.
To improve the UFM1 synthesis, we devised a practical
native chemical ligation (NCL) strategy to generate full-
length UFM1 based on a N-terminal peptide thioester
fragment (AA 1–44) and C-terminal peptide fragment (AA
45–83) with alanine at position 45 replaced by a cysteine
(Scheme 1). This method permitted the generation of full-
length UFM1 and a complete repertoire of probes in an
efficient manner using a minimal amount of building blocks
(Scheme 1).
Using SPPS and standard coupling conditions (namely
4 equiv Fmoc-protected amino acid, 4 equiv PyBOP, 8 equiv
DIPEA, and double coupling cycles), we prepared the N-
terminal fragment (AA 1–44) on a hyper-acid labile trityl
resin to give amine 1 or functionalized its N-termini with
a Rhodamine 110 fluorophore (2).[37] Then, selective cleavage
from the resin with 20 % hexafluoro-2-propanol (HFIP) in
CH2Cl2 liberated the C-terminal carboxylate leaving all other
protective groups in place. The C-terminal carboxylate was
then converted into the mercaptomethylpropionate thioester
by reaction with mercaptomethylpropionate, followed by
global deprotection and HPLC purification. Subsequently,
the C-terminal fragment (A45C-83, 3) was obtained by Fmoc-
based SPPS, followed by global deprotection and HPLC
purification.
Native chemical ligation of the N-terminal thioester-
fragment (1 or 2) and C-terminal cysteine-fragment (3) was
performed under denaturing conditions in 8m Gdn·HCl
containing 100 mm tris(2-carboxyethyl)phosphine (TCEP)
and 100 mm mercaptophenylacetic acid (MPAA) at pH 7.6
and 37 8C. Conversion to the full-length UFM1 product (6 or
7) proceeded very efficiently in just 30 min. Precipitation
from water and subsequent redissolution in Gdn·HCl fol-
lowed by radical desulfurization using VA-044, glutathione,
and TCEP for 16 h at 37 8C resulted in formation of the full-
length native UFM1 as the cysteine residue at the ligation site
was converted into the native alanine. Subsequent HPLC
purification followed by gel-filtration yielded UFM1 and
Rho-UFM1 in 85% and 79 % yield, respectively.
Correct folding of purified synthetic UFM1 (Figure 2A)
was verified by circular dichroism (CD) spectroscopy (Fig-
ure 2B). To further verify the correct folding and thus
biochemical function, we compared synthetic and recombi-
nant UFM1 in an enzymatic reaction with UBA5 (E1).
Efficient formation of the UBA5 ~UFM1 thioester proved
that synthetic UFM1 is processed with the same efficiency as
recombinant UFM1 (Figure 2C and Figure S3).
Having developed a convenient UFM1 synthesis, we then
focused on the generation of a UFM1-based toolbox to enable
Figure 1. Schematic illustration of the UFM1 toolbox featuring activity-
based probes to study preference and selectivity of both proteases and
ligases by covalently capturing active enzymes.
Scheme 1. Native chemical ligation strategy towards native UFM1 and
UFM1 activity-based probes.
Figure 2. Validation of synthetic UFM1. A) SDS-PAGE gel showing
synthetic and expressed UFM1. B) CD measurements of expressed
UFM1 and synthetic UFM1 made by linear synthesis or native
chemical ligation. Synth. FL= UFM1 generated by linear synthesis;
Synth. NCL =UFM1 generated by NCL (6). C) UBA5 reacts with both
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the profiling and visualization of all enzymes involved in the
Ufmylation cascade (Figure 1, Scheme 1). For this purpose,
we synthesized UFM1-Dha to target the conjugating class of
enzymes[26] and UFM1-PA to target the proteases.[24] To
achieve this, we synthesized a C-terminal fragment lacking
the last amino acid (A45C-82). Upon cleavage from the resin
with HFIP, the C-termini were equipped with either Cys(Bn)-
OMe (4) or propargylamide (5). After global deprotection
and HPLC purification, the desired C-terminal fragments
were obtained and subsequently used in a NCL reaction as
described above. ABP precursors for the UFM1 ligase probe
(8) was successfully constructed by NCL followed by a radical
desulfurization reaction to obtain UFM1-Cys(Bn)-OMe. This
was subsequently transformed by oxidative elimination with
O-mesitylenesulfonylhydroxyl-amine (MSH). Finally, the
methyl ester was hydrolysed, to generate the UFM1-Dha
probe (8). ABPs targeting UFM1-specific cysteine proteases
(9–10) were easily constructed by native chemical ligation as
well. However, one limitation we encountered was that the
remaining cysteine after NCL could not be desulphurized, as
radical desulfurization conditions compromise the integrity of
the propargyl warhead. But since the ligation position (AA
45) is situated outside the critical C-terminal region for UFM1
recognition by Ufsp enzymes,[38] we expect this small thiol
group to be tolerated. Furthermore, the routine addition of
1,4-dithiothreitol (DTT) to the enzymatic assay reaction
buffers reduces any potential disulfide bridges occurring at
this cysteine that might affect enzymatic processing.
With these ABPs in hand, we tested their reactivity
towards UFM1 ligases and proteases in cell lysates. Firstly, we
assessed the reactivity of the E1 enzyme-UBA5-towards Rho-
UFM1-Dha (8). Similar to UbDha, UFM1-Dha forms an
adenylate with the C-terminal glycine of UFM1. The acti-
vated methylene group of this adenylate intermediate can
then undergo a nucleophilic attack of the active-site cysteine
to yield either the covalent UBA5-UFM1-thioether adduct or
the UBA5-UFM1~ thioester[26] (Figure 3A). Upon reacting
UBA5 with the ligase probe Rho-UFM1-Dha (8), a complex
is formed that remains stable in the presence of DTT,
indicative of the thioether bond formed between the active
site cysteine and the dehydroalanine moiety of 8 in contrast to
the thioester bond formed between UBA5 and UFM1 (7)
(Figure 3B and Figure S3). Furthermore, UFM1-Dha does
not display cross-reactivity towards UBE1, the Ub-activating
E1 enzyme, or towards the Ufm1-specific protease Ufsp1
underscoring the selectivity of this ABP (Figures S4 and S5).
Next, we tested our UFM1-PA protease probe.[34] As
expected, Rho-UFM1-PA (10) generated by NCL (containing
Cys-45) showed comparable reactivity towards Ufsp1 as the
Rho-UFM1-PA probe generated by linear SPPS (containing
the native Ala-45), indicating that the cysteine at this position
does not interfere with protease recognition, which is in
agreement with literature[38] (Figure S6). Given that human
Ufsp1 is thought to be catalytically inactive (Figure S7), we
assessed the reactivity of the active murine Ufsp1 instead. To
this end, HEK293 cells transiently overexpressing Flag-
tagged murine Ufsp1 or untransfected cells were lysed and
incubated with Rho-UFM1-PA at 37 8C (Figure 4A). Visual-
ization by in-gel fluorescence scanning followed by immuno-
blotting revealed that Ufsp1 engages more readily than Ufsp2
with this ABP[3] (Figure 4B and Figure S8). While murine
Ufsp1 completely reacts with UFM1-PA after 45 min, endog-
enous Ufsp2 engages with UFM1-PA after prolonged incu-
bation of nearly 6 h (Figure 4A,B). The two UFM1-specific
proteases known to date are cysteine-proteases exhibiting
a conserved papain-like fold with the classical catalytic Cys–
His–Asp triad but share no sequence homology with DUBS
Figure 3. Reactivity of E1 (UBA5) towards UFM1. A) Scheme depicting
the reactivity of UBA5 towards UFM1-Dha permitting the formation of
either the thioether (a) or the thioester adduct (b). B) SDS-PAGE gel of
reaction of synthetic UFM1 (6) or Rho-UFM1-Dha (8) and recombinant
UBA5.
Figure 4. Assessment of UFM1-PA reactivity and specificity against
a panel of cysteine protease subfamilies. A) Immunoblot showing
time-dependent reactivity of Flag-Ufsp1 (murine) towards Rho-UFM1-
PA (10), B) and time-dependent labeling of endogenous Ufsp2
(human). C,F) DUBs Flag-UCHL-1 and GFP-OTUB2 do not react with
UFM1-PA. D,E) Flag-SENP6 and Flag-SENP1 react with S2-PA
(= SUMO2-PA) but are unreactive towards UFM1-PA. For fluorescence
scans and actin blots see Figure S8.
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or Ub-like-protein-specific proteases (ULPs) but rather
constitute a new cysteine protease subfamily.[20,21] To assess
whether deubiquitinating enzymes (DUBs) and SUMO-
specific proteases (SENPs) display cross reactivity towards
UFM1-PA, a panel of representative deubiquitinating and
deSUMOylating enzymes were profiled. As expected, only
UFM-1 specific proteases recognize and bind specifically to
UFM1-PA (Figure 4C–F and Figure S8).
Subsequently, we addressed the efficacy of UFM1-PA by
monitoring UFM1 protease activity in a cellular environment
by electroporation of Rho-UFM1-PA (10) into HeLa cells
ectopically expressing Flag-Ufsp1 or its catalytically inactive
C53A mutant as previously described.[26] In-gel fluorescence
analysis followed by immunoblotting revealed labeling of
endogenous Ufsp2 in cells with Rho-UFM1-PA, while in
Ufsp2-depleted HeLa cells reactivity was abolished (see
Figure 5A and Figures S9 and S10). As expected, only active
Flag-Ufsp1 reacted with UFM1-PA but not its catalytically
inactive version. Having demonstrated that our UFM1 ABP
probe can be used to monitor enzymatic reactivity in living
cells, we used the fluorescent ABP to visualize Ufsp reactivity
by confocal microscopy. After introduction of Rho-UFM1-PA
by electroporation into either unmodified or HeLa cells
ectopically transfected with murine Flag-Ufsp1, probe distri-
bution was observed both throughout the cytoplasm and the
nucleus (Figure 5B). However, incorporation of 10 into HeLa
cells ectopically expressing murine Flag-Ufsp1 or its catalyti-
cally inactive C53A mutant, showed substantial co-localiza-
tion with wild-type but not with the catalytically incompetent
enzyme (Figure 5C).
In conclusion, we present a practical native chemical
ligation-based synthetic approach for generating UFM1
activity-based probes. Using this facile strategy, a wide variety
of UFM1 ABPs equipped with fluorescent tags, as well as
diverse reactive groups targeting proteases or ligases are
accessible. The strategies presented in this study highlight
a variety of assays and possibilities to utilize our ABPs in the
interrogation of enzymatic activities in the Ufmylation
cascade. The straightforward nature of the experimental
setup is expected to make them readily adoptable to
comparative profiling in the presence of various perturba-
tions, facilitating the understanding of UFM1 biology and
additionally potentiate the discovery of specific UFM1
enzyme inhibitors. We anticipate that our toolset will greatly
facilitate ongoing studies on the UFM1 enzyme cascade.
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